Mutant having uracil phosphoribosyl transferase activity

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S093100, C514S04400A, C435S320100, C435S325000, C435S455000

Reexamination Certificate

active

07572438

ABSTRACT:
The invention concerns a polypeptide having a uracil phosphoribosyl transferase (UPRTase) by mutation of one or several residues of the UPRTase. The invention also concerns a nucleotide sequence coding for the UPRTase mutant, a vector for expressing the latter, a viral particle, a host cell, and a composition containing them. The invention further concerns their therapeutic use and a treatment method using them. The invention is particularly useful in the context of therapy by suicide genes, in particular, for treating proliferative and infectious diseases.

REFERENCES:
patent: 5856153 (1999-01-01), Tiraby et al.
patent: 6066624 (2000-05-01), Woo et al.
patent: 96/16183 (1996-05-01), None
Oonuma, et al. Gene therapy for intraperitoneally disseminated pancreatic cancers byEscherichia coliuracil phophoribosiltransferase (UPRT) gene mediated by restricted replication-competent adenoviral vectors. International Journal of Cancer, 2002. 102:51-59.
Bourbeau, et al. Suicide gene therapy with an adenovirus expressing the fusion gene CD:UPRT in human glioblastomas: different sensitivities correlate with p53 status. The Journal of Gene Medicine, 2004. 6:1320-1332.
Hadaczek et al (Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclover gene therapy for brain tumors. Journal of Neurosurgery, 2005 102:318-335).
Gura (Systems for Identifying New Drugs Are Often Faulty. Science, 1997. 278:1041-1042).
Kem, L. et al., “The FUR1 Gene ofSaccharomyces cerevisiae: Cloning, Structure and Expression of Wild-Type and Mutant Alleles”, Gene Apr. 16, 1990, 88(2), 149-57, Elsevier Science Publishers B.V. (Biomedical Division).
Martinussen et al., “Two Genes Encoding Uracil-Phosphoribosyltransferase are present inBacillus subtilis,” J. Bacteriol. 177 (1):271-274, Jan. 1995, Am. Soc. Of Microbiology, Wash., D.C.
GenBank Acc. No. CAB11230, “Uracil Phosphoribosyltransferase (Schizosaccharomyces Pombe),” US Natl. Library of Medicine, Bethesda, MD, Apr. 4, 2000, accessed by PTO on 04 No. 2002.
Ngo et al., “Computational Complexity, Protein Structure Prediction, and the Leventhal Paradox”, In The Protein Folding Problem and Tertiary Structure Prediction, Merz et al., (eds.), Birkhauser Boston: Boston, MA, pp. 433 and 492-495; 1994.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mutant having uracil phosphoribosyl transferase activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mutant having uracil phosphoribosyl transferase activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant having uracil phosphoribosyl transferase activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4123062

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.